CuInP<sub>2</sub>S<sub>6</sub> Captures Virus for Viral Inhibition and Vaccine Adjuvanticity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41860110.
- Also identified by DOI 10.1021/acs.nanolett.5c04910.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The development of broad-spectrum antiviral agents and effective vaccine adjuvants remains a critical challenge. Herein, we report biodegradable CuInP<sub>2</sub>S<sub>6</sub> (CIPS) nanosheets as a dual-functional material that enables direct viral interception and potent immunoenhancement. Its action stems from a functional paradigm we term CIPS-dependent cellular phagocytosis, wherein CIPS binds viral particles and leverages intrinsic phagocytic clearance to promote macrophage-mediated viral uptake and degradation. This process not only directly neutralizes viruses but also enhances antigen presentation and facilitates dendritic cell activation, thereby establishing the foundation for its adjuvant function. Consequently, in a murine immunization model, the CIPS-adjuvanted formulation elicited a significantly stronger humoral immune response, including elevated antigen-specific IgG titers and robust neutralizing antibody induction, even with a monomeric receptor-binding domain antigen. This work elucidates how the antiviral mechanism of CIPS translates into potent immunoenhancement, offering a novel strategy for applying functional nanomaterials in vaccine development.
Medical subject headings
- Adjuvants, Vaccine
- Copper
- Antiviral Agents
- Nanostructures
- Adjuvants, Immunologic